Publication | Closed Access

6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial

Percutaneous Coronary InterventionThrombosisCardiovascular DiseaseClinical TrialsAcute Coronary SyndromeNon-inferiority TrialAcute Myocardial InfarctionPlatelet AntagonistMedicineCardiologyEmergency MedicineCoronary Artery Disease